Mark Thomas Miller

USPTO Granted Patents = 110 (Patent Applications = 52)

CIPO Patents = 7 (Patent Applications = 19)

EPO Patents = 24 (Patent Applications = 52)

Average Co-Inventor Count = 5.4

ph-index = 52

Forward Citations = 5,267(Granted Patents)

Inventors with similar research interests:

Location History:

San Diego, CA (US) (2002 - 2024)
Rancho Santa Fe, CA (US) (2022 - 2024)

Company Filing History:

104 out of 1,149

Vertex Pharmaceuticals, Inc.

University of California

patents

Years Active: 2002-2025

Loading Chart...

110 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421251 - Cystic fibrosis transmembrane conductance regulator modulating agents (2025-09-23),

2. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2025-08-12),

3. RE50453 - Indole derivatives as CFTR modulators (2025-06-10),

4. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-06-10),

5. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

6. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-04-08),

7. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator (2024-12-17),

8. 12122788 - Process of making CFTR modulators (2024-10-22),

9. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

10. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2024-01-09),

11. 11639347 - Modulators of ATP-binding cassette transporters (2023-05-02),

12. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator (2023-02-28),

13. 11584761 - Process of making CFTR modulators (2023-02-21),

14. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2022-09-27),

15. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator (2022-08-30),

Title: Mark Thomas Miller: A Pioneer of Innovation

Introduction:

Mark Thomas Miller, a visionary inventor hailing from San Diego, CA, with a staggering 102 patents under his belt, continues to be a beacon of inspiration for aspiring inventors worldwide. His relentless pursuit of innovation has solidified his position as a true trailblazer in the realm of inventions.

Latest Patents:

Among his latest patents are groundbreaking advancements in the pharmaceutical industry. Mark Thomas Miller has unveiled crystalline forms of CFTR modulators and innovative compounds for treating cystic fibrosis. These patents not only showcase his expertise in the field but also highlight his dedication to improving healthcare through inventive solutions.

Career Highlights:

Throughout his illustrious career, Mark Thomas Miller has made significant contributions to companies like Vertex Pharmaceuticals, Inc. and Viasat, Inc. His expertise and innovative spirit have helped drive these organizations towards success in the ever-evolving landscape of technology and healthcare.

Collaborations:

Collaborating with esteemed coworkers such as Jinglan Zhou and Sara Sabina Hadida Ruah, Mark Thomas Miller has been able to harness the power of teamwork to bring his inventive ideas to life. These collaborations have not only fostered creativity but have also led to the development of groundbreaking technologies.

Conclusion:

In conclusion, Mark Thomas Miller's unwavering dedication to innovation and his remarkable track record of patents serve as a testament to his legacy as a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors to push boundaries, think outside the box, and strive for excellence in their pursuits of innovative solutions to societal challenges.

This text is generated by artificial intelligence and may not be accurate.